Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
GLIPITA M 50/500MG is indicated for the treatment of type 2 diabetes mellitus when diet and exercise alone are insufficient to control blood sugar.
Pharmacology:
GLIPITA M contains glipizide, which stimulates insulin secretion from pancreatic beta cells, and metformin, which decreases hepatic glucose production and improves insulin sensitivity.
Dosage:
Dose is individualized based on patient's response. Usually taken twice daily with meals to minimize gastrointestinal side effects.
Administration:
Orally, swallow tablets with water during or after meals.
Interaction:
May interact with other hypoglycemic drugs, corticosteroids, diuretics, beta-blockers, and alcohol, affecting blood sugar control.
Contraindications:
-
Type 1 diabetes
-
Diabetic ketoacidosis
-
Severe renal or hepatic impairment
-
Allergy to glipizide or metformin
Side Effects:
-
Hypoglycemia
-
Gastrointestinal upset (nausea, vomiting, diarrhea)
-
Weight gain
-
Rare risk of lactic acidosis
-
Allergic reactions
Pregnancy & Lactation:
Use only if prescribed by doctor; limited safety data. Insulin preferred in pregnancy.
Precautions & Warnings:
-
Monitor blood glucose and kidney function regularly
-
Avoid alcohol
-
Adjust dose during illness or surgery
-
Stop before radiologic studies with iodine contrast
Therapeutic Class:
Oral hypoglycemic agent — Combination of sulfonylurea and biguanide
Storage Conditions:
Store in a cool, dry place below 30°C, away from sunlight and moisture. Keep out of reach of children.
 30PCS.jpg)
 60 ML.jpg)
 10025 100 MG 25 MG.jpg)
 350ML.jpg)
 100 IU.jpg)
 100 IU.jpg)
 20025 20025.jpg)
 350ML.jpg)
.jpg)
 400MG.jpg)
.jpg)
 15050160.jpg)
Change Language